Research ArticleHuman Studies
Radiolabeled Chimeric Anti-CEA Monoclonal Antibody Compared with the Original Mouse Monoclonal Antibody for Surgically Treated Colorectal Carcinoma
Franz Buchegger, Jean-Pierre Mach, André Pèlegrin, Michel Gillet, Charles-André Vogel, Thierry Buclin, Jean-Etienne Ryser, Bernard Delaloye and Angelika Bischof Delaloye
Journal of Nuclear Medicine March 1995, 36 (3) 420-429;
Franz Buchegger
Jean-Pierre Mach
André Pèlegrin
Michel Gillet
Charles-André Vogel
Thierry Buclin
Jean-Etienne Ryser
Bernard Delaloye
Angelika Bischof Delaloye


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Radiolabeled Chimeric Anti-CEA Monoclonal Antibody Compared with the Original Mouse Monoclonal Antibody for Surgically Treated Colorectal Carcinoma
Franz Buchegger, Jean-Pierre Mach, André Pèlegrin, Michel Gillet, Charles-André Vogel, Thierry Buclin, Jean-Etienne Ryser, Bernard Delaloye, Angelika Bischof Delaloye
Journal of Nuclear Medicine Mar 1995, 36 (3) 420-429;
Radiolabeled Chimeric Anti-CEA Monoclonal Antibody Compared with the Original Mouse Monoclonal Antibody for Surgically Treated Colorectal Carcinoma
Franz Buchegger, Jean-Pierre Mach, André Pèlegrin, Michel Gillet, Charles-André Vogel, Thierry Buclin, Jean-Etienne Ryser, Bernard Delaloye, Angelika Bischof Delaloye
Journal of Nuclear Medicine Mar 1995, 36 (3) 420-429;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Improved Tumor Responses with Sequential Targeted {alpha}-Particles Followed by Interleukin 2 Immunocytokine Therapies in Treatment of CEA-Positive Breast and Colon Tumors in CEA Transgenic Mice
- Adjuvant Radioimmunotherapy Trial with Iodine-131-Labeled Anti-Carcinoembryonic Antigen Monoclonal Antibody F6 F(ab')2 after Resection of Liver Metastases from Colorectal Cancer
- FDG PET and Immunoscintigraphy with 99mTc-Labeled Antibody Fragments for Detection of the Recurrence of Colorectal Carcinoma